Treatment of Bacterial Vaginosis

First-Line Treatment Options

• The Centers for Disease Control and Prevention recommends oral metronidazole 500 mg twice daily for 7 days as the preferred treatment with the highest efficacy (95% cure rate) 1, 2, 3
• Metronidazole gel 0.75%, one full applicator (5g) intravaginally once daily for 5 days is equally effective as oral therapy but with fewer systemic side effects 1, 3
• Clindamycin cream 2%, one full applicator (5g) intravaginally at bedtime for 7 days is another effective first-line option 2, 3

Alternative Treatment Options

• Oral metronidazole 2g as a single dose has lower efficacy (84% cure rate) compared to the 7-day regimen but may be useful when compliance is a concern 1, 2, 3
• Oral clindamycin 300 mg twice daily for 7 days is an alternative when metronidazole cannot be used 1, 3

Special Populations

Pregnancy

• The American College of Obstetricians and Gynecologists recommends that all symptomatic pregnant women should be tested and treated for BV 1, 3
• During first trimester: Clindamycin vaginal cream is preferred due to contraindication of metronidazole 2, 4
• During second and third trimesters: Metronidazole 250 mg orally three times daily for 7 days is recommended 2
• Treatment of BV in high-risk pregnant women (history of preterm delivery) may reduce risk of prematurity 1

HIV Infection

• The Centers for Disease Control and Prevention recommends that patients with HIV and BV should receive the same treatment as persons without HIV 2, 3, 4

Treatment Considerations

Side Effects and Precautions

• Patients using metronidazole should avoid alcohol during treatment and for 24 hours afterward due to potential disulfiram-like reaction 1, 2, 3
• Clindamycin cream and ovules are oil-based and may weaken latex condoms and diaphragms 1, 3
• Metronidazole may cause gastrointestinal upset and unpleasant taste; intravaginal preparations have fewer systemic side effects 2, 5

Allergy or Intolerance to Metronidazole

• Clindamycin cream or oral clindamycin is preferred for patients with allergy or intolerance to metronidazole 1, 3
• Patients allergic to oral metronidazole should not be administered metronidazole vaginally 2, 3

Follow-Up and Recurrence Management

• Follow-up visits are unnecessary if symptoms resolve 1, 2, 3

Management of Sex Partners

• Routine treatment of male sex partners is not recommended as it has not been shown to influence a woman's response to therapy or reduce recurrence rates 2, 3

Special Clinical Situations

• Before surgical abortion or hysterectomy, screening and treating women with BV is recommended due to increased risk for postoperative infectious complications 3
• Treatment of BV with metronidazole has been shown to substantially reduce post-abortion PID 2, 3

Treatment of Bacterial Vaginosis in Breastfeeding Women

Special Considerations for Breastfeeding Women

• The Centers for Disease Control and Prevention guidelines can be applied to breastfeeding women, as metronidazole is considered compatible with breastfeeding 6, 7
• While small amounts of metronidazole are excreted in breast milk, the amount is not significant enough to cause harm to the infant 8, 9

Allergy or Intolerance to Metronidazole

• Clindamycin cream or oral clindamycin is preferred for patients with allergy or intolerance to metronidazole 6, 7
• Patients allergic to oral metronidazole should not be administered metronidazole vaginally 6, 7

Treatment Precautions

• Patients using metronidazole should avoid alcohol during treatment and for 24 hours afterward due to potential disulfiram-like reaction 8
• Clindamycin cream and ovules are oil-based and may weaken latex condoms and diaphragms 8, 9

Follow-Up and Recurrence Management

• Follow-up visits are unnecessary if symptoms resolve 7, 8
• Patients should be advised to return for additional therapy if symptoms recur 7, 8

Management of Sex Partners

• Routine treatment of male sex partners is not recommended as it has not been shown to influence a woman's response to therapy or reduce recurrence rates 6, 7

Treatment of Bacterial Vaginosis in Perimenopausal Women

Understanding BV Risk in Perimenopause

• Perimenopausal women experience hormonal fluctuations that can disrupt the vaginal microbiome, creating conditions favorable for BV development through decreased estrogen levels affecting lactobacilli populations, as noted by the American Family Physician 10
• The treatment approach for BV in perimenopausal women remains consistent with standard BV management, as all symptomatic women require treatment regardless of menopausal status, according to the American Family Physician 10, 11

First-Line Treatment Options

• Oral metronidazole 500 mg twice daily for 7 days relieves vaginal symptoms and reduces risk for infectious complications after procedures like abortion or hysterectomy, as recommended by the American Family Physician 10, 11

Treatment of Bacterial Vaginosis in Breastfeeding Patients

Safety Considerations for Breastfeeding

• Intravaginal preparations, such as metronidazole gel, result in minimal systemic absorption, achieving less than 2% of standard oral dose serum concentrations, according to the CDC guidelines as reported in MMWR Recommendations and Reports 12
• The use of intravaginal preparations, such as metronidazole gel or clindamycin cream, minimizes systemic side effects, including gastrointestinal upset and unpleasant taste, as noted in MMWR Recommendations and Reports 12

Important Treatment Precautions

• Asymptomatic bacterial vaginosis in breastfeeding women should not be treated unless they are undergoing surgical procedures like abortion or hysterectomy, where treatment reduces postoperative infectious complications, as recommended by MMWR Recommendations and Reports 12